Cardioprotective effect of propofol in cardioplegia compared to systemic propofol in heart valves surgery; a randomized controlled trial - Trial PACTR201907764652028
Access comprehensive clinical trial information for PACTR201907764652028 through Pure Global AI's free database. This Phase 4 trial is sponsored by Tanta University Hospital and is currently Completed. The study focuses on Surgery.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Tanta University Hospital
self funding
Timeline & Enrollment
Phase 4
Nov 11, 2018
May 20, 2022
Summary
Cardiac surgery now is surrounded by alot of risk factors and the myocardial protection strategies is the way for the researchers to find out. Our goal is to detect the cardioprotective effect of the propofol whether in cardioplegia or systemically.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR201907764652028
Non-Device Trial